Organization
AstraZeneca Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
AstraZeneca Plc
... AstraZeneca and MedImmune, its global biologics research and development arm, head to the ...
... he is Executive Vice President, Global Medicines Development & Chief Medical Officer, Astrazeneca. Mark J O'Connor declares that he is Chief Scientist, Oncology, Head of ...
... here: Disclosure: Baptist Gallwitz discloses the following: Board Member/Advisory Panel for Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly & Co., Janssen, Merck Sharp & Dohme, Mylan, ...
... of Alzheimer's disease (with Allergan) and immuno-oncology approaches to treat cancer (with AstraZeneca). Sosei's additional partners and collaborators include Novartis, Pfizer, Daiichi-Sankyo, PeptiDream, Kymab and ...
... and D2, histamine H1, and adrenergic alpha 1 and alpha 2 receptors. AstraZeneca initially launched Seroquel in the US and Europe in 1997 for the ...
... voluntary health organization devoted to fighting cardiovascular disease, supported by funding from AstraZeneca, is seeking to expand in-hospital cardiovascular care guideline adherence through the Improving ...
... software solutions for biopharmaceutical R&D, today announced that its collaborative project with AstraZeneca -Deep Learning for Phenotypic Image Analysis- received the 2018 Bio-IT World Best ...
... 3 between 8:00am and 11:30am. Based on these preliminary results, Innate's partner AstraZeneca/MedImmune progressed the combination with standard of care therapies. About Monalizumab: Monalizumab is ...
... AstraZeneca today announced results from the Phase III SYGMA trials1,2 of Symbicort Turbuhaler(budesonide/formoterol) ...
... US REGULATORS have given the green light to a crucial drug in Astra-Zeneca's pipeline, two years after blocking approval because of concerns over the way ...
Subscribe now for full coverage on AstraZeneca Plc
Start My Free Trial